Related Experiment Video
Updated: Apr 16, 2026
Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
Published on: August 9, 2022
Monocytes in myocardial infarction
Partha Dutta1, Matthias Nahrendorf2
1From the Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston. Dutta.Partha@mgh.harvard.edu.
Insights
Understanding monocyte roles in heart attack repair is key. New therapies targeting monocyte signals after myocardial infarction (MI) could improve cardiac healing and reduce heart failure risk.
Area of Science:
- Cardiovascular Science
- Immunology
- Regenerative Medicine
Background:
- Myocardial infarction (MI) remains a leading cause of death, with high long-term morbidity despite revascularization.
- The post-MI period involves rapid tissue turnover, including extracellular matrix digestion and fibrosis, making repair critical.
- Monocytes are essential for debris removal and repair in the infarcted myocardium, but excessive inflammation can hinder healing.
Purpose of the Study:
- To elucidate the roles and regulation of monocyte subsets during myocardial infarction (MI) repair.
- To identify therapeutic targets for improving cardiac healing and mitigating heart failure post-MI.
Main Methods:
- The study focuses on the two-phase recruitment of monocytes (Ly-6c(high) and Ly-6c(low)) to the infarcted myocardium post-MI.
- Analysis of monocyte differentiation pathways, specifically Ly-6c(high) to Ly-6c(low) macrophages, during later healing stages.
Main Results:
- Monocyte recruitment to the infarcted myocardium occurs in two distinct phases, initially dominated by Ly-6c(high) monocytes.
- Ly-6c(low) monocyte recruitment is less pronounced, though Ly-6c(high) monocytes can differentiate into Ly-6c(low) macrophages.
- Elevated white blood cell counts correlate with increased in-hospital mortality after MI, suggesting a role for inflammation control.
Conclusions:
- Understanding the signals that regulate monocyte numbers and function after MI is crucial for developing novel therapeutic strategies.
- Targeting monocyte responses holds promise for enhancing cardiac repair and reducing the incidence of heart failure following myocardial infarction.
Abstract:
Myocardial infarction (MI) is the leading cause of death in developed countries. Though timely revascularization of the ischemic myocardium and current standard therapy reduce acute mortality after MI, long-term morbidity and mortality remain high. During the first 1 to 2 weeks after MI, tissues in the infarcted myocardium undergo rapid turnover, including digestion of extracellular matrix and fibrosis. Post-MI repair is crucial to survival. Monocytes recruited to the infarcted myocardium remove debris and facilitate the repair process. However, exaggerated inflammation may also impede healing, as demonstrated by the association between elevated white blood cell count and in-hospital mortality after MI. Monocytes produced in the bone marrow and spleen enter the blood after MI and are recruited to the injured myocardium in 2 phases. The first phase is dominated by Ly-6c(high) monocytes and the second phase by Ly-6c(low) monocytes. Yet the number of Ly6C(low) monocytes recruited to the infarct is much lower, and Ly6C(high) monocytes can differentiate to Ly6C(low) macrophages in later healing stages. Understanding the signals regulating monocytosis after MI will help design new therapies to facilitate cardiac healing and limit heart failure.
Related Concept Videos
01:21Myocarditis I: Introduction
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...